Prevalence, impact, and management of depression and anxiety in patients with HIV: a review

References

• World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: World Health Organization; 2007:8.
   Google Scholar
• WHO [webpage on the Internet]. Health Topics. HIV/AIDS Online. Geneva, World Health Organization, 2016. Available from: http://www.who.int/topics/hiv_aids/en/. Accessed February 24, 2016.
   Google Scholar
• Bravo P, Edwards A, Rollnick S, Elwyn G. Tough decisions faced by people living with HIV: a literature review of psychosocial problems. AIDS Rev. 2010;12(2):76–88.
   PubMed Web of Science ®Google Scholar
• Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–728.
   PubMed Web of Science ®Google Scholar
• Robertson K, Bayon C, Molina JM, et al. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. AIDS Care. 2014;26(12):1555–1561.
   PubMed Web of Science ®Google Scholar
• Andrinopoulos K, Clum G, Murphy DA, et al; Adolescent Medicine Trials Network for HIVAIDS Interventions. Health related quality of life and psychosocial correlates among HIV-infected adolescent and young adult women in the US. AIDS Educ Prev. 2011;23:367–381.
   PubMed Web of Science ®Google Scholar
• Peter E, Kamath R, Andrews T, Hegde BM. Psychosocial determinants of health-related quality of life of people living with HIV/AIDS on antiretroviral therapy at Udupi District, Southern India. Int J Prev Med. 2014;5(2):203–209.
   PubMedGoogle Scholar
• Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14–25.
   PubMedGoogle Scholar
• Psaros C, O’Cleirigh C, Bullis JR, Markowitz SM, Safren SA. The influence of psychological variables on health-related quality of life among HIV-positive individuals with a history of intravenous drug use. J Psychoactive Drugs. 2013;45(4):304–312.
   PubMed Web of Science ®Google Scholar
• Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–269.
   PubMed Web of Science ®Google Scholar
• Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev. 2005;25(4):433–457.
   PubMed Web of Science ®Google Scholar
• Simoni JM, Safren SA, Manhart LE, et al. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav. 2011;15(2):376–388.
   PubMed Web of Science ®Google Scholar
• Schuster R, Bornovalova M, Hunt E. The influence of depression on the progression of HIV: direct and indirect effects. Behav Modif. 2012;36(2):123–145.
   PubMed Web of Science ®Google Scholar
• Phillips KD, Sowell RL, Rojas M, Tavakoli A, Fulk LJ, Hand GA. Physiological and psychological correlates of fatigue in HIV disease. Biol Res Nurs. 2004;6(1):59–74.
   PubMedGoogle Scholar
• Dubé B, Benton T, Cruess DG, Evans DL. Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci. 2005;30:237–246.
   PubMed Web of Science ®Google Scholar
• Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–730.
   PubMed Web of Science ®Google Scholar
• Elenga N, Georger-Sow MT, Messiaen T, et al. Incidence and predictive factors of depression among patients with HIV infection in Guadeluope: 1988–2009. Int J STD AIDS. 2014;25(8):559–563.
   Web of Science ®Google Scholar
• Nacher M, Adriouch L, Godard Sebillotte C, et al. Predictive factors and incidence of anxiety and depression in a cohort of HIV-positive patients in French Guiana. AIDS Care. 2010;22(9):1086–1092.
   PubMed Web of Science ®Google Scholar
• Ohaeri JU, Jegede RO. Depression and the general medical practitioner in Nigeria. Medicare. 1991;6:7–11.
   Google Scholar
• Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163–171.
   PubMedGoogle Scholar
• Willard S, Holzemer WL, Wantland DJ, et al. Does “asymptomatic” mean without symptoms for those living with HIV infection? AIDS Care. 2009;21(3):322–328.
   PubMed Web of Science ®Google Scholar
• Belete A, Andaregie G, Tareke M, Birhan T, Azale T. Prevalence of anxiety and associated factors among people living with HIV/AIDS at Debretabor general hospital anti retro viral clinic Debretabor, Amhara, Ethiopia, 2014. Am J Psychiatry Neurosci. 2014;2(6):109–114.
   Google Scholar
• Perkins DO, Stern RA, Golden RN, Murphy C, Naftolowitz D, Evans DL. Mood disorders in HIV infection. Prevalence and risk factors in a non epicenter of the AIDS epidemic. Am J Psychiatry. 1994;15:233–236.
   Google Scholar
• Gaynes BN, O’Donnell J, Nelson E, et al. Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. Gen Hosp Psychiatry. 2015;37(4):277–282.
   PubMed Web of Science ®Google Scholar
• Sale S, Gadanya M. Prevalence and factors associated with depression in HIV/AIDS patients aged 15-25 years at Aminu Kano Teaching Hospital, Nigeria. J Child Adolesc Ment Health. 2008;20(2):95–99.
   PubMedGoogle Scholar
• Lu SH, Tang XP, Deng XL, Chen WL, Hu RX. Relationship between psychological distress and T lymphocyte in HIV/AIDS patients. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009;23(1):23–25.
   Google Scholar
• Musisi S, Kinyanda E. Emotional and behavioural disorders in HIV seropositive adolescents in urban Uganda. East Afr Med J. 2009;86(1):16–24.
   PubMedGoogle Scholar
• Nüesch R, Gayet-Ageron A, Chetchotisakd P, et al; STACCATO Study Group. The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients. Open AIDS J. 2009;3:38–45.
   PubMedGoogle Scholar
• Marwick KF, Kaaya SF. Prevalence of depression and anxiety disorders in HIV-positive outpatients in rural Tanzania. AIDS Care. 2010;22(4):415–419.
   PubMed Web of Science ®Google Scholar
• Clarke TR, Gibson RC, Barrow G, Abel WD, Barton EN. Depression among persons attending a HIV/AIDS outpatient clinic in Kingston, Jamaica. West Indian Med J. 2010;59(4):369–373.
   PubMed Web of Science ®Google Scholar
• Sivasubramanian M, Mimiaga MJ, Mayer KH, et al. Suicidality, clinical depression, and anxiety disorders are highly prevalent in men who have sex with men in Mumbai, India: findings from a community-recruited sample. Psychol Health Med. 2011;16(4):450–462.
   PubMed Web of Science ®Google Scholar
• Morrison SD, Banushi VH, Sarnquist C, et al. Levels of self-reported depression and anxiety among HIV-positive patients in Albania: a cross-sectional study. Croat Med J. 2011;52(5):622–628.
   Web of Science ®Google Scholar
• Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV Infection are at high risk for depression and poor linkage to care. AIDS Behav. 2011;15(6):1161–1170.
   PubMed Web of Science ®Google Scholar
• Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry. 2011;11:205.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Srivastava K, Goyal S, Chaudhury S. Psychosocial correlates of human immunodeficiency virus infected patients. Ind Psychiatry J. 2012;21(1):55–60.
   Google Scholar
• Pappin M, Wouters E, Booysen FL. Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study. BMC Public Health. 2012;12:244.
   PubMed Web of Science ®Google Scholar
• L’akoa RM, Noubiap JJ, Fang Y, Ntone FE, Kuaban C. Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon. BMC Psychiatry. 2013;13:228.
   PubMed Web of Science ®Google Scholar
• Su X, Lau JT, Mak WW, et al. Prevalence and associated factors of depression among people living with HIV in two cities in China. J Affect Disord. 2013;149:108–115.
   PubMed Web of Science ®Google Scholar
• Talukdar A, Ghosal MK, Sanyal D, et al. Determinants of quality of life in HIV-infected patients receiving highly active antiretroviral treatment at a medical college ART center in Kolkata, India. J Int Assoc Provid AIDS Care. 2013;12(4):284–290.
   Google Scholar
• Olagunju AT, Ogundipe OA, Erinfolami AR, Akinbode AA, Adeyemi JD. Toward the integration of comprehensive mental health services in HIV care: an assessment of psychiatric morbidity among HIV-positive individuals in sub-Saharan Africa. AIDS Care. 2013;25(9):1193–1198.
   PubMed Web of Science ®Google Scholar
• Song JY, Lee JS, Seo YB, et al. Depression among HIV-infected patients in Korea: assessment of clinical significance and risk factors. Infect Chemother. 2013;45(2):211–216.
   PubMedGoogle Scholar
• Liu L, Pang R, Sun W, et al. Functional social support, psychological capital, and depressive and anxiety symptoms among people living with HIV/AIDS employed full-time. BMC Psychiatry. 2013;13:324.
   PubMed Web of Science ®Google Scholar
• Chauhan VS, Chaudhury S, Sudarsanan S, Srivastava K. Psychiatric morbidity in asymptomatic human immunodeficiency virus patients. Ind Psychiatry J. 2013;22(2):125–130.
   Google Scholar
• Levy I, Goldstein A, Fischel T, Maor Y, Litachevsky V, Rahav G. Neurocognitive disturbances and psychiatric disorders among patients living with HIV-1 positive in Israel. Harefuah. 2013;152(4):196–199.
   Google Scholar
• Nel A, Kagee A. The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa. AIDS Care. 2013;25(8):948–955.
   PubMed Web of Science ®Google Scholar
• Largu MA, Dorob CM, Prisacariu L, Nicolau C, Astrstoae V, Manciuc C. The psycho-emotional profile of the HIV-positive naïve patient. Rev Med Chir Soc Med Nat Iasi. 2014;118(3):733–737.
   Google Scholar
• Kim MH, Mazenga AC, Devandra A, et al. Prevalence of depression and validation of the Beck Depression Inventory-II and the Children’s Depression Inventory-Short amongst HIV-positive adolescents in Malawi. J Int AIDS Soc. 2014;17:18965.
   PubMed Web of Science ®Google Scholar
• Kittner JM, Brokamp F, Thomaidis T, et al. Disclosure and experienced social support are not related to anxiety or depression in a German HIV patient cohort. Infect Chemother. 2014;46(2):77–83.
   Google Scholar
• Bhatia MS, Munjal S. Prevalence of depression in people living with HIV/AIDS undergoing ART and factors associated with it. J Clin Diagn Res. 2014;8(10):1–4.
   PubMedGoogle Scholar
• Sun W, Wu M, Qu P, Lu C, Wang L. Psychological well-being of people living with HIV/AIDS under the new epidemic characteristics in China and the risk factors: a population-based study. Int J Infect Dis. 2014;28:147–152.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Luo D, Cheng R, et al. Emotional problems and related factors in patients with HIV/AIDS. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(8):835–841.
   Google Scholar
• Glémaud M, Illa L, Echenique M, et al. Abuse and mental health concerns among HIV-infected Haitian women living in the United States. J Assoc Nurses AIDS Care. 2014;25(1 suppl):S62–S69.
   Google Scholar
• Lowther K, Selman L, Harding R, Higginson IJ. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): a systematic review. Int J Nurs Stud. 2014;51(8):1171–1189.
   PubMed Web of Science ®Google Scholar
• Kee MK, Lee SY, Kim NY, et al. Anxiety and depressive symptoms among patients infected with human immunodeficiency virus in South Korea. AIDS Care. 2015;27(9):1174–1182.
   PubMed Web of Science ®Google Scholar
• Nomoto SH, Longhi RM, de Barros BP, Croda J, Ziff EB, Castelon Konkiewitz E. Socioeconomic disadvantage increasing risk for depression among recently diagnosed HIV patients in an urban area in Brazil: cross-sectional study. AIDS Care. 2015;5:1–7.
   Google Scholar
• Slot M, Sodemann M, Gabel C, Holmskov J, Laursen T, Rodkjaer L. Factors associated with risk of depression and relevant predictors of screening for depression in clinical practice: a cross-sectional study among HIV-infected individuals in Denmark. HIV Med. 2015;16(7):393–402.
   PubMed Web of Science ®Google Scholar
• Olagunju AT, Adeyemi JD, Ogbolu RE, Campbell EA. A study on epidemiological profile of anxiety disorders among people living with HIV/AIDS in a sub-Saharan Africa HIV clinic. AIDS Behav. 2012;16(8):2192–2197.
   PubMed Web of Science ®Google Scholar
• Ivanova EL, Hart TA, Wagner AC, Aljassem K, Loutfy MR. Correlates of anxiety in women living with HIV of reproductive age. AIDS Behav. 2012;16(8):2181–2191.
   PubMed Web of Science ®Google Scholar
• Celesia BM, Nigro L, Pinzone MR, et al. High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study. Eur Rev Med Pharmacol Sci. 2013;17(15):2040–2046.
   Web of Science ®Google Scholar
• Parhami I, Fong TW, Siani A, Carlotti C, Khanlou H. Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California. AIDS Behav. 2013;17(8):2792–2801.
   Web of Science ®Google Scholar
• Zisook S, Peterkin J, Goggin KJ, Sledge P, Atkinson JH, Grant I. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. J Clin Psychiatry. 1998;59:217–224.
   PubMed Web of Science ®Google Scholar
• Asch SM, Kilbourne AM, Gifford AL, et al. Under diagnosis of depression in HIV. J Gen Intern Med. 2003;18:450–460.
   PubMed Web of Science ®Google Scholar
• Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568–2573.
   PubMed Web of Science ®Google Scholar
• Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466–1474.
   PubMed Web of Science ®Google Scholar
• Habib SE. AIDS, Sex Work and Gender: Researching Female Sex Workers in Bangladesh. In: Hossain KT, Imam MH, Habib SE, editors. Women Gender and Discrimination. Rajshahi: Higher Education Link Programme; 2004:155–170.
   Google Scholar
• Valverdee EE, Purcell D, Waldrop-Valverfe D, et al. Correlates of depression among HIV-positive women and men who inject drugs. J Acquir Immune Defic Syndr. 2007;46(suppl 2):S96–S100.
   Google Scholar
• Frank E, Carpenter LL, Kupfer DJ. Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry. 1988;145:41–45.
   PubMed Web of Science ®Google Scholar
• Young EA. Glucocorticoid cascade hypothesis revisited: role of gonadal steroids. Depression. 1990;3:20–27.
   Google Scholar
• Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychiatry. 1999;156:480–482.
   PubMed Web of Science ®Google Scholar
• Ofovwe CE, Ofovwe C. Psychological disorders among human immunodeficiency virus-infected adults in southern Nigeria. Afr J Reprod Health. 2013;17(4 Spec No):177–182.
   Google Scholar
• Saadat M, Behboodi ZM, Saadat E. Comparison of depression, anxiety, stress, and related factors among women and men with human immunodeficiency virus infection. J Hum Reprod Sci. 2015;8(1):48–51.
   PubMedGoogle Scholar
• Lopes M, Olfson M, Rabkin J, et al. Gender, HIV status, and psychiatric disorders: results from the national epidemiologic study on alcohol and related conditions. J Clin Psychiatry. 2012;73(3):384–391.
   PubMed Web of Science ®Google Scholar
• Jallow A, Ljunggren G, Wändell P, Carlsson AC. Prevalence, incidence, mortality and co-morbidities amongst human immunodeficiency virus (HIV) patients in Stockholm County, Sweden – the Greater Stockholm HIV Cohort Study. AIDS Care. 2015;27(2):142–149.
   PubMed Web of Science ®Google Scholar
• Owe-Larsson B, Sall L, Salamon E, Allgulander C. HIV infection and psychiatric illness. Afr J Psychiatry (Johannesbg). 2009;12:115–128.
   PubMed Web of Science ®Google Scholar
• Atkinson JH, Heaton RK, Patterson TL, et al. Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord. 2008;108(3):225–234.
   PubMed Web of Science ®Google Scholar
• Sewell MC, Goggin KJ, Rabkin JG, Ferrando SJ, McElhiney MC, Evans S. Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics. 2000;41:294–300.
   PubMed Web of Science ®Google Scholar
• Ferrando S, Goggin K, Sewell M, Evans S, Fishman B, Rabkin J. Substance use disorders in gay/bisexual men with HIV and AIDS. Am J Addict. 1998;7:51–60.
   PubMed Web of Science ®Google Scholar
• Chandra PS, Ravi V, Desai A. Anxiety and depression among HIV-infected heterosexuals- a report from India. J Psychosom Res. 1998;45:401–409.
   PubMed Web of Science ®Google Scholar
• Orlando M, Burnam A, Beckman R, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2001;11(2):75–82.
   Web of Science ®Google Scholar
• Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–254.
   PubMed Web of Science ®Google Scholar
• Tsao JC, Dobalian A, Naliboff BD. Panic disorder and pain in a national sample of persons living with HIV. Pain. 2004;109:172–180.
   PubMed Web of Science ®Google Scholar
• Summers J, Zisook S, Atkinson JH, et al. Psychiatric morbidity associated with acquired immunodeficiency syndrome-related grief resolution. J Nerv Ment Dis. 1995;183:384–389.
   PubMed Web of Science ®Google Scholar
• Haller DL, Miles DR. Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of life. AIDS Behav. 2003;7(2):101–108.
   PubMed Web of Science ®Google Scholar
• Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–580.
   PubMed Web of Science ®Google Scholar
• Wilkins JW, Robertson KR, Snyder CR, Robertson WK, van der Horst C, Hall CD. Implications of self-reported cognitive and motor dysfunctions in HIV-positive patients. Am J Psychiatry. 1991;148(5):641–643.
   PubMed Web of Science ®Google Scholar
• Coughlin SS. Anxiety and depression: linkages with viral diseases. Public Health Rev. 2012;34(2):92.
   Google Scholar
• Katz S, Nevid JS. Risk factors associated with posttraumatic stress disorder symptomatology in HIV-infected women. AIDS Patient Care STDS. 2005;19:110–120.
   PubMed Web of Science ®Google Scholar
• Soller M, Kharrazi N, Prentiss D, et al. Utilization of psychiatric services among low-income HIV-infected patients with psychiatric comorbidity. AIDS Care. 2011;23:1351–1359.
   PubMed Web of Science ®Google Scholar
• Martin L, Kagee A. Lifetime and HIV-related PTSD among persons recently diagnosed with HIV. AIDS Behav. 2011;15:125–131.
   PubMed Web of Science ®Google Scholar
• Radcliffe J, Fleisher CL, Hawkins LA, et al. Posttraumatic stress and trauma history in adolescents and young adults with HIV. AIDS Patient Care STDS. 2007;21:501–508.
   PubMed Web of Science ®Google Scholar
• Brief DJ, Bollinger AR, Vielhauer MJ, et al. Understanding the interface of HIV, trauma, post-traumatic stress disorder, and substance use and its implications for health outcomes. AIDS Care. 2004;16:S97–S120.
   PubMed Web of Science ®Google Scholar
• Beckerman NL, Auerbach C. PTSD and HIV in women: the role of gender in this dual diagnosis. Women Health. 2011;51:497–510.
   PubMed Web of Science ®Google Scholar
• Theuninck AC, Lake N, Gibson S. HIV-related posttraumatic stress disorder: investigating the traumatic events. AIDS Patient Care STDS. 2010;24:485–491.
   PubMed Web of Science ®Google Scholar
• Chander G, Himelhoch S, Moore R. Substance abuse and psychiatric disorder in HIV-positive patients. Drugs. 2006;66:769–789.
   PubMed Web of Science ®Google Scholar
• Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17(1):530.
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Hanson A, Fishman M, McHugh PR, Treisman GJ. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med. 1994;24(2):103–113.
   PubMed Web of Science ®Google Scholar
• Savetsky JB, Sullivan LM, Clarke J, Stein MD, Samet JH. Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. J Nerv Ment Dis. 2001;189(2):76–83.
   Web of Science ®Google Scholar
• Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol. 2001;54(suppl 1):S44–S52.
   PubMed Web of Science ®Google Scholar
• de Ronchi D, Faranca I, Forti P, et al. Development of acute psychotic disorders and HIV-1 infection. Int J Psychiatry Med. 2000;30(2):173–183.
   PubMed Web of Science ®Google Scholar
• Khan N, Loewenson R. Guidelines for Reducing Stigma and Discrimination and Enhancing Care and Support for People Living with HIV and AIDS. Harare: Training and Research Support Centre; South African Network of AIDS Service Organizations and European Commission; 2005.
   Google Scholar
• Li L, Lee SJ, Thammawijaya P, Jiraphongsa C, Rotheram-Borus MJ. Stigma, social support, and depression among people living with HIV in Thailand. AIDS Care. 2009;21(8):1007–1013.
   PubMed Web of Science ®Google Scholar
• Kamen C, Arganbright J, Kienitz E, et al. HIV-related stigma: implications for symptoms of anxiety and depression among Malawian women. Afr J AIDS Res. 2015;14(1):67–73.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gong H, Yang G, Yan J. Perceived stigma, mental health and unsafe sexual behaviors of people living with HIV/AIDS. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(7):658–663.
   PubMedGoogle Scholar
• Rao D, Choi SW, Victorson D, et al. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual Life Res. 2009;18(5):585–595.
   PubMed Web of Science ®Google Scholar
• Corrigan P, Watson A, Barr L. The self-stigma of mental illness: implications for self esteem and self efficacy. J Soc Clin Psychol. 2006;25(9):875–884.
   Web of Science ®Google Scholar
• Hatzenbuehler ML, O’Cleirigh C, Mayer KH, Mimiaga MJ, Safren SA. Prospective associations between HIV-related stigma, transmission risk behaviors, and adverse mental health outcomes in men who have sex with men. Ann Behav Med. 2011;42(2):227–234.
   PubMed Web of Science ®Google Scholar
• Shacham E, Rosenburg N, Önen NF, Donovan MF, Overton ET. Persistent HIV-related stigma among an outpatient US clinic population. Int J STD AIDS. 2015;26(4):243–250.
   PubMed Web of Science ®Google Scholar
• Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Res Ther. 2011;8:8.
   PubMed Web of Science ®Google Scholar
• Assefa Y, Van Damme W, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24(8):521–525.
   PubMed Web of Science ®Google Scholar
• Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: a qualitative study. SAHARA J. 2009;6(4):148–154.
   PubMed Web of Science ®Google Scholar
• Maedot P, Haile A, Lulseged S, Belachew A. Determinants of vct uptake among pregnant women attending two ANC clinics in Addis Ababa City: unmatched case control study. Ethiop Med J. 2007;45(4):335–342.
   PubMedGoogle Scholar
• Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinol Lett. 2011;32(1):7–24.
   PubMed Web of Science ®Google Scholar
• Del Guerra FB, Fonseca JL, Figueiredo VM, Ziff EB, Konkiewitz EC. Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neurovirol. 2013;19(4):314–327.
   Web of Science ®Google Scholar
• Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev. 2010;6(3):205–212.
   PubMedGoogle Scholar
• Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurosurg Psychiatry. 2012;83(5):495–502.
   Web of Science ®Google Scholar
• McGuire JL, Kempen JH, Localio R, Ellenberg JH, Douglas SD. Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol. 2015;22(1):27–36.
   Google Scholar
• Mothapo KM, Schellekens A, van Crevel R, et al. Improvement of depression and anxiety after discontinuation of long-term efavirenz treatment. CNS Neurol Disord Drug Targets. 2015;14(6):811–818.
   Web of Science ®Google Scholar
• Pedrol E, Llibre JM, Tasias M, et al. Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study. HIV Med. 2015;16(10):628–634.
   Web of Science ®Google Scholar
• Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6–17.
   PubMed Web of Science ®Google Scholar
• Katon WJ. Clinical and health services relationships between major depression, de pressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226.
   PubMed Web of Science ®Google Scholar
• Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45(suppl 4):S313–S317.
   PubMedGoogle Scholar
• Sternhell PS, Corr MJ. Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. Aust N Z J Psychiatry. 2002;36:528–533.
   PubMed Web of Science ®Google Scholar
• Adejumo O, Oladeji B, Akpa O, et al. Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria. Int J STD AIDS. Epub Sep 18 2015.
   Google Scholar
• Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–2143.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
   PubMed Web of Science ®Google Scholar
• Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54:295–306.
   PubMed Web of Science ®Google Scholar
• Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CDS T lymphocytes and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159:1752–1759.
   PubMed Web of Science ®Google Scholar
• Ironson G, Balbin E, Solomon G, et al. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS. 2001;15(16):2065–2073.
   PubMed Web of Science ®Google Scholar
• Cruess DG, Douglas SD, Petitto JM, et al. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry. 2005;162(11):2125–2130.
   Web of Science ®Google Scholar
• Grossman F, Potter WZ. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Psychiatry Res. 1999;87:21–27.
   Web of Science ®Google Scholar
• Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133–1140.
   PubMed Web of Science ®Google Scholar
• Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394–402.
   PubMed Web of Science ®Google Scholar
• Starace F, Ammassari A, Trotta MP, et al. Depression Is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(suppl 3):s136–s139.
   PubMed Web of Science ®Google Scholar
• Waldrop-Valverde D, Valverde E. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care STDS. 2005;19:326–334.
   PubMed Web of Science ®Google Scholar
• Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr. 2010;53:266–272.
   PubMed Web of Science ®Google Scholar
• Repetto MJ, Petitto JM. Psychopharmacology in HIV-infected patients. Psychosom Med. 2008;70(5):585–592.
   Web of Science ®Google Scholar
• Gallego L, Barreiro P, Lopez-Ibor JJ. Psychopharmacological treatments in HIV patients under antiretroviral therapy. AIDS Rev. 2012;14:101–111.
   PubMed Web of Science ®Google Scholar
• Kang E, Delzell DA, Chhabra M, Oberdorfer P. Factors associated with high rates of antiretroviral medication adherence among youth living with perinatal HIV in Thailand. Int J STD AIDS. 2015;26(8):534–541.
   PubMed Web of Science ®Google Scholar
• Vitello B, Burnam M, Bing E, Beckman R, Shapiro M. Use of psychotropic medications among HIV-infected patients in United States. Am J Psychiatry. 2003;160:547–554.
   Web of Science ®Google Scholar
• Freudenreich O, Goforth H, Cozza K, et al. Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices. Psychosomatics. 2010;51:480–488.
   Web of Science ®Google Scholar
• Omonuwa T, Goforth H, Preud’homme X, et al. The pharmacological management of insomnia in patients with HIV. J Clin Sleep Med. 2009;5:251–262.
   PubMed Web of Science ®Google Scholar
• Batki S. Buspirone in drug users with AIDS or AIDS – related complex. J Clin Psychopharmacol. 1990;10:111–115.
   Google Scholar
• Greenblatt D, von Moltke L, Harmatz J, et al. Differential impairment of triazolam and zolpidem clearance by ritonavir. J Acquir Immune Defic Syndr. 2000;24:129–136.
   PubMed Web of Science ®Google Scholar
• Anderson I. Selective serotonin reuptake inhibitors versus tricyclic antidepressants; a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19–36.
   PubMed Web of Science ®Google Scholar
• Grassi B, Gambini O, Garghentini G, Lazzarin A, Scarone S. Efficacy of paroxetine for treatment of depression in the context of HIV infection. Pharmacotherapy. 1997;30:70–71.
   Google Scholar
• Fernando S, Rabkin J, de Moore G, Rabkin R. Antidepressant treatment of depression in HIV seropositive women. J Clin Psychiatry. 1999;60:741–746.
   Web of Science ®Google Scholar
• Baker G, Fang H, Sinha S, Coults R. Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev. 1998;22:325–333.
   PubMed Web of Science ®Google Scholar
• Caballero J, Nahata M. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Ann Pharmacother. 2005;39:141–145.
   PubMed Web of Science ®Google Scholar
• Currier M, Molina G, Kato M. Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: a prospective study. Psychosomatics. 2004;45:210–216.
   PubMed Web of Science ®Google Scholar
• DeSilva KE, Le Flore DB, Marston BJ, Rimland D. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS. 2001;15:1281–1285.
   PubMed Web of Science ®Google Scholar
• Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–390.
   PubMed Web of Science ®Google Scholar
• Elliott AJ, Uldall KK, Bergam K, Russo J, Claypoole K, Roy-Byrne PP. Randomized, placebo- controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry. 1998;155:367–372.
   PubMed Web of Science ®Google Scholar
• Schwartz JAJ, McDaniel JS. Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study. Depress Anxiety. 1999;9(2):70–74.
   PubMedGoogle Scholar
• Younai FS, Marcus M, Freed JR, et al. Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:629–636.
   PubMed Web of Science ®Google Scholar
• Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP. Antidepressant efficacy in HIV seropositive outpatients with major depressive disorder: an open trial of nefazodone. J Clin Psychiatry. 1999;60(4):226–231.
   Web of Science ®Google Scholar
• Elliott AJ, Roy-Byrne PP. Mirtazapine for depression in patients with human immunodeficiency virus. J Clin Psychopharmacol. 2000;20(2):265–267.
   PubMed Web of Science ®Google Scholar
• Ereshefsky L, Dugan D. Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine. Depress Anxiety. 2000;12:30–44.
   PubMed Web of Science ®Google Scholar
• Currier M, Molina G, Kato M. A prospective trial of sustained release bupropion for depression in HIV-seropositive and AIDS patients. Psychosomatics. 2003;44:120–125.
   PubMed Web of Science ®Google Scholar
• Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab Dispos. 2001;29:100–102.
   PubMed Web of Science ®Google Scholar
• Carvarhal A, de Abreu P, Spode A, Correa J, Kapczinski F. An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry. 2003;64:421–424.
   Web of Science ®Google Scholar
• Fernandez F, Levy JK, Samley HR, et al. Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine. Int J Psychiatry Med. 1995;25:53–67.
   PubMed Web of Science ®Google Scholar
• Wagner GJ, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial. J Clin Psychiatry. 2000;61:436–440.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology. 2000;25:53–68.
   PubMed Web of Science ®Google Scholar
• Lee MR, Cohen L, Hadley SW, Goodwin FK. Cognitive-behavioral group therapy with medication for depressed gay men with AIDS or symptomatic HIV infection. Psychiatr Serv. 1999;50:948–952.
   PubMed Web of Science ®Google Scholar
• Crepaz N, Passin WF, Herbst JH, et al. Meta-analysis of cognitive-behavioral interventions on HIV-positive persons’ mental health and immune functioning. Health Psychol. 2008;27(1):4–14.
   PubMed Web of Science ®Google Scholar
• Spies G, Asmal L, Seedat S. Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review. J Affect Disord. 2013;150(2):171–180.
   PubMed Web of Science ®Google Scholar
• Markowitz JC, Klerman GL, Clougherty KF, et al. Individual psychotherapies for depressed HIV positive patients. Am J Psychiatry. 1995;152:1504–1509.
   PubMed Web of Science ®Google Scholar
• Markowitz JC, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patient. Arch Gen Psychiatry. 1998;55:452–457.
   PubMed Web of Science ®Google Scholar
• Rousaud A, Blanch J, Hautzinger M, et al. Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot study. AIDS Patient Care STDS. 2007;21(3):212–222.
   Web of Science ®Google Scholar
• Mulder CL, Emmelkamp PM, Antoni MH, Mulder JW, Sandfort TG, de Vries MJ. Cognitive behavioral and experiential group psychotherapy for HIV-infected homosexual men: a comparative study. Psychosom Med. 1994;56:423–431.
   PubMed Web of Science ®Google Scholar
• Lutgendorf SK, Antoni MH, Ironson G, et al. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIV seropositive gay men. J Consult Clin Psychol. 1997;65:31–43.
   PubMed Web of Science ®Google Scholar
• Cruess S, Antoni MH, Hayes A, et al. Changes in mood and depressive symptoms and related change processes during cognitive – behavioral stress management in HIV infected men. Cognit Ther Res. 2002;26:373–392.
   Web of Science ®Google Scholar
• Blanch J, Rousaud A, Hautzinger M, et al. Assessment of the efficacy of a cognitive-behavioral group psychotherapy programme for HIV infected patients referred to a consultation-liaison psychiatry department. Psychother Psychosom. 2002;71:77–84.
   PubMed Web of Science ®Google Scholar
• Antoni MH, Cruess S, Cruess DG, et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med. 2000;22:29–37.
   PubMed Web of Science ®Google Scholar
• Olatunji BO, Mimiaga MJ, O’Cleirigh C, Safren SA. A review of treatment studies of depression in HIV. Top HIV Med. 2006;14(3):112–124.
   PubMedGoogle Scholar
• Berger S, Schad T, von Wyl V, et al. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS. 2008;22(6):767–775.
   PubMed Web of Science ®Google Scholar
• Brown JL, Vanable PA. Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med. 2008;35(1):26–40.
   PubMed Web of Science ®Google Scholar
• Scott-Sheldon LA, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 2008;27(2):129–139.
   PubMed Web of Science ®Google Scholar
• Hemmati Sabet A, Khalatbari J, Abbas Ghorbani M, Haghighi M, Ahmadpanah M. Group training of stress management vs. group cognitive-behavioral therapy in reducing depression, anxiety and perceived stress among HIV-positive men. Iran J Psychiatry Behav Sci. 2013;7(1):4–8.
   PubMedGoogle Scholar
• Vance DE, Humphrey SC, Nicholson WC, Jablonski-Jaudon R. Can speed of processing training ameliorate depressive symptomatology in adults with HIV? Ann Depress Anxiety. 2014;1(3):4.
   Google Scholar
• Ngô TL. Review of the effects of mindfulness meditation on mental and physical health and its mechanisms of action. Sante Ment Que. 2013;38(2):19–34.
   Google Scholar
• Hand GA, Lyerly GW, Jaggers JR, Dudgeon WD. Impact of aerobic and resistance exercise on the health of HIV-infected persons. Am J Lifestyle Med. 2009;3(6):489–499.
   PubMedGoogle Scholar